Allen TM - Search Results

1

Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil.

Hare JI, Neijzen RW, Anantha M, Dos Santos N, Harasym N, Webb MS, Allen TM, Bally MB, Waterhouse DN. Hare JI, et al. Among authors: allen tm. PLoS One. 2013 Apr 23;8(4):e62349. doi: 10.1371/journal.pone.0062349. Print 2013. PLoS One. 2013. PMID: 23626804 Free PMC article.

2

Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.

Allen TM, Cheng WW, Hare JI, Laginha KM. Allen TM, et al. Anticancer Agents Med Chem. 2006 Nov;6(6):513-23. doi: 10.2174/187152006778699121. Anticancer Agents Med Chem. 2006. PMID: 17100556 Review.

3

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer.

Hare JI, Moase EH, Allen TM. Hare JI, et al. Among authors: allen tm. J Drug Target. 2013 Jan;21(1):87-96. doi: 10.3109/1061186X.2012.729215. Epub 2012 Oct 8. J Drug Target. 2013. PMID: 23039213

4

Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity.

Charrois GJ, Allen TM. Charrois GJ, et al. Among authors: allen tm. J Pharmacol Exp Ther. 2003 Sep;306(3):1058-67. doi: 10.1124/jpet.103.053413. Epub 2003 Jun 13. J Pharmacol Exp Ther. 2003. PMID: 12808004

5

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Laginha KM, Moase EH, Yu N, Huang A, Allen TM. Laginha KM, et al. Among authors: allen tm. J Drug Target. 2008 Aug;16(7):605-10. doi: 10.1080/10611860802229978. J Drug Target. 2008. PMID: 18686132

6

Targeting Stealth liposomes in a murine model of human small cell lung cancer.

Moreira JN, Gaspar R, Allen TM. Moreira JN, et al. Among authors: allen tm. Biochim Biophys Acta. 2001 Dec 1;1515(2):167-76. doi: 10.1016/s0005-2736(01)00411-4. Biochim Biophys Acta. 2001. PMID: 11718672 Free article.

7

Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors.

Laginha KM, Verwoert S, Charrois GJ, Allen TM. Laginha KM, et al. Among authors: allen tm. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6944-9. doi: 10.1158/1078-0432.CCR-05-0343. Clin Cancer Res. 2005. PMID: 16203786

8

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.

Moase EH, Qi W, Ishida T, Gabos Z, Longenecker BM, Zimmermann GL, Ding L, Krantz M, Allen TM. Moase EH, et al. Among authors: allen tm. Biochim Biophys Acta. 2001 Feb 9;1510(1-2):43-55. doi: 10.1016/s0005-2736(00)00334-5. Biochim Biophys Acta. 2001. PMID: 11342146 Free article.

9

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.

Charrois GJ, Allen TM. Charrois GJ, et al. Among authors: allen tm. Biochim Biophys Acta. 2004 May 27;1663(1-2):167-77. doi: 10.1016/j.bbamem.2004.03.006. Biochim Biophys Acta. 2004. PMID: 15157619 Free article.

10

Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

Cheng WW, Allen TM. Cheng WW, et al. Among authors: allen tm. J Control Release. 2008 Feb 18;126(1):50-8. doi: 10.1016/j.jconrel.2007.11.005. Epub 2007 Nov 17. J Control Release. 2008. PMID: 18068849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters